The review from the Drug and Therapeutics Bulletin on managing difficult to treat asthma1 states that studies of novel biological agents have shown marked improvements in the frequency of exacerbations… Click to show full abstract
The review from the Drug and Therapeutics Bulletin on managing difficult to treat asthma1 states that studies of novel biological agents have shown marked improvements in the frequency of exacerbations and healthcare consumption and reductions in oral steroid dosage but that limited evidence shows benefits in quality of life. Failure to detect quality of life …
               
Click one of the above tabs to view related content.